Interim Results

RNS Number : 9841Z
CareCapital Group plc
30 September 2009
 



30th September 2009



CareCapital Group Plc

("CareCapital" or "the Group")

Interim Report for the Six Months to 30 June 2009


CareCapital Group Plc (AIM: CARE), a healthcare real estate developer and investor in the UK and in Germany, is pleased to announce its interim report for the six months to 30 June 2009.


Highlights

  • Group rental income up 21% to £1,596,719 (HI 2008: £1,312,661)

  • Adjusted diluted Net Asset Value ("NAV") per share* 18.5p (H1 2008: 22.5p)

  • Loss before tax of £880,005 (H1 2008 Profit: £20,049) 

  • Development pipeline in the UK and Germany with a combined value of £87 million

*Adjusted diluted net asset per share - excludes deferred tax on property portfolio revaluation. Calculated on a similar basis for 2008.



Dr. Michael Sinclair, Chairman, commented"I remain convinced that the development of, and investment in, medical office buildings remains one of the most stable long term property related activities and that this will continue to be the case for the foreseeable future. This is reflected by the recent valuation exercises which reinforce the real worth of the Company" 


For further information, please contact:

CareCapital Group Plc

Daniel Stewart & Co. Plc

Tavistock Communications

Paul Stacey, Chief Executive

Steve Wilden, Finance Director

Simon Leathers, Corporate Finance


Simon Hudson 

Paul Young


Tel: 020 7034 1949

Tel: 020 7776 6550

Tel: 020 7920 3150

pstacey@carecapital.co.uk

swilden@carecapital.co.uk

simon.leathers@danielstewart.co.uk

shudson@tavistock.co.uk

pyoung@tavistock.co.uk 



 





Chairman's Statement


I am pleased to present the financial results for the CareCapital Group Plc for the six months to 30 June 2009.


At 30 June 2009 the Group's investment properties and developments in progress were valued at £57.6 million (31.12.08: £55.8 million; 30.6.08: £49.6 million). Adjusted diluted Net Asset Value per share (which excludes deferred tax on property revaluations) was 18.5p at 30 June; (31.12.08: 20.9p). Group rental income for the six months under review was £1.6 million (2008: £1.3 million)


The period under review and the subsequent months to date have presented challenges which your Board has striven to address. The Board's view is that it would not have been in the interests of shareholders to raise funds through the market at a valuation significantly below net asset value. Consequently the Company has to date procured further short term secured borrowings of just under £5 million net of costs of which I have personally provided £4.2 million.


My senior management colleagues and I, as was announced on 6 April 2009, explored the option of a management buy out of the Group. However, the receipt of third party expressions of interest in respect of the acquisition of all or part of the Group resulted in our decision to terminate the management buy out option, as announced on 6 April 2009, in order to ensure no conflict of interest in considering any other financing offers. The Board is currently considering the potential outcome of this process and is evaluating the options for the future direction and status of the Group and its financing requirements. 


In order to assess any firm proposals relating to the acquisition of the Group or any part of it, we have engaged, since 30 June 2009, an international firm of chartered surveyors to perform a valuation of the investment property portfolios in the UK and Germany. This report has recently been completed and has produced a gross valuation of the UK Portfolio of £23 million (excluding the Folkestone Dental Centre) and Germany of €26.6 million. This has reinforced the valuation shown in the 2008 Annual Report and Accounts.


Additionally, the Group has a number of projects at advanced stages of development ("the development pipeline"); all of which are currently expected to proceed. Consequently the Directors have commissioned an independent firm of accountants to value the development pipeline.  Based on the expected rental values and current rental yields in the sector, this places a residual value (before seller's costs) on the development pipeline in the range of between £8 million and £11.1 million.  In arriving at the residual valuation, all future development costs have been deducted and the expected completion dates of the various projects have been taken into account.


If this valuation of the development pipeline were to be incorporated into the Group's assets it would produce an increase in net assets per share of between 10.4p and 14.4 p.


The outcome of these valuation exercises has not been incorporated into the half year financial results.


Development activity and the securing of associated long term debt continues in line with the Board's expectations. As previously reported we completed the development in Marktredwitz, Northern Bavaria, in December 2008 and it was fully tenanted by the end of March 2009. The construction of our second medical office building in Adlershof, South East Berlin is on schedule with completion due before the end of March 2010. This building is fully pre let.


In the UK it is anticipated that the projects in Coventry and Consett will be on site by early November 2009. An unexpected casualty of the present economic conditions has been the dental tenants at Folkestone, who are unable to meet the obligations of the lease. In seeking redress under the terms of the lease compensation has been agreed with one of the guarantors. The Group is actively seeking alternative tenants and as a consequence, the property is valued in the accounts at cost.

 

I remain convinced that the development of, and investment in, medical office buildings remains one of the most stable long term property related activities and that this will continue to be the case for the foreseeable future.



Dr Michael Sinclair,

Chairman

30th September 2009



CareCapital Group Plc

Consolidated income statement for the six months ended 30 June 2009








Six months

Six months

Year







ended

ended

ended







30 June

30 June

31 December







2009

2008

2008







Unaudited

Unaudited

Audited

 

 

 

 

 

Notes

£

£

£








Revenue

 

 

 

 

 

1,596,719

1,312,661

2,856,110

Cost of sales

 

 

 

 

(203,817)

(178,086)

(416,025)

Gross profit





1,392,902

1,134,575

2,440,085

Administrative expenses

 

 

 

(939,268)

(802,180)

(1,750,826)

Net surplus / (deficit) on revaluation of investment properties



130,511

254,525

(1,655,932)

Operating profit / (loss)





584,145

586,920

(966,673)

Finance income





676

287,537

1,208,929

Finance costs





(1,464,826)

(874,324)

(2,548,868)

Change in fair value of financial instruments

 

 

-

19,916

92,256

Net finance costs

 

 

 

 

(1,464,150)

(566,871)

(1,247,683)

(Loss) / Profit before tax





(880,005)

20,049

(2,214,356)

Taxation

 

 

 

 

 

-

(76,844)

524,195

(Loss) / Profit on ordinary activities after taxation

 

(880,005)

(56,795)

(1,690,161)

(Loss) / Profit for the period







 - attributable to equity shareholders



(905,825)

(70,966)

(1,688,027)

 - attributable to minority interests

 

 

25,820

14,171

(2,134)







(880,005)

(56,795)

(1,690,161)


(Loss) / Earnings per Ordinary Share









 -Basic



5

(1.15)p

(0.09)p

(2.20)p




- Diluted



5

(1.15)p

(0.09)p

(2.20)p


Weighted average number of shares ('000)

 

5

76,754

76,754

76,754


The above results relate to continuing operations.



CareCapital Group Plc

Statement of comprehensive income for the six months ended 30 June 2009 


 
 
 
 
 
Six months
Six months
Year
 
 
 
 
 
ended
ended
ended
 
 
 
 
 
30 June
30 June
31 December
 
 
 
 
 
2009
2008
2008
 
 
 
 
 
Unaudited
Unaudited
Audited
 
 
 
 
 
£
£
£

(Loss) / Profit for the period

(880,005)

(56,795)

(1,690,161)

Other comprehensive income:








Exchange differences on translating foreign operations

(960,581)

125,978 

488,168 

 

 

 

 

Other comprehensive income for the period, net of tax

(960,581)

125,978

488,168





Total comprehensive income for the period

(1,840,586)

69,183 

(1,201,993)









Total comprehensive income attributable to:








Owners of the parent

(1,835,362)

44,885 

(1,248,676)

Minority interest

(5,224)

24,298 

46,683 

 

 

 

 

 

(1,840,586)

69,183 

(1,201,993)




CareCapital Group Plc

Consolidated statement of financial position at 30 June 2009






As at

As at

As at





30 June

31 December

30 June





2009

2008

2008





Unaudited

Audited

Unaudited

 

 

 

 

£

£

£

Non - current assets





Intangible assets



1,751,959

1,751,959

1,965,615

Investment properties



49,367,932

52,331,824

41,883,741

Development properties


8,236,752

3,512,716

7,703,083

Leasehold improvements


75,003

79,914

84,825

Plant and equipment

 

 

62,247

58,941

45,063





59,493,894

57,735,354

36,294,850

Current assets






Trade and other receivables


314,274

465,181

632,328

Cash and cash equivalents


178,216

2,519,519

245,252



492,490

2,984,700

877,580


Total assets

 

 

59,986,384

60,720,054

52,559,907


Current liabilities






Trade and other payables


(2,785,647)

(1,940,940)

(1,533,558)

Borrowings, including finance leases

(4,609,067)

(4,438,452)

(3,805,223)

Derivative financial instruments

 

-

-

(72,340)

Total Current Liabilities


(7,394,713)

(6,379,392)

(5,411,121)


Non - current liabilities





Borrowings, including finance leases

(38,408,437)

(38,327,667)

(29,434,026)

Deferred tax provision

 

(2,103,420)

(2,103,420)

(2,704,459)





(40,511,857)

(40,431,087)

(32,138,485)


Total liabilities

 

 

(47,906,571)

(46,810,479)

(37,549,606)


Net assets

 

 

12,079,813

13,909,575

15,010,301


Equity







Share capital



767,541

767,541

767,541

Share premium account



1,397,500

1,397,500

1,397,500

Share option reserve


401,430

390,606

220,156

Reverse acquisition reserve


11,038,204

11,038,204

11,038,204

Exchange movements reserve


(486,133)

443,404

119,904

Profit and Loss account

 

(1,209,294)

(303,469)

1,313,592

Equity shareholders interest


11,909,248

13,733,786

14,856,897

Minority interest

 

 

170,565

175,789

153,404

Total equity

 

 

12,079,813

13,909,575

15,010,301




CareCapital Group Plc

Consolidated statement of changes in equity for the six months ended 30 June 2009




Share

Share

Share

Reverse

Exchange

rate

Profit and

Equity 

Minority

Total




capital

premium

  options

acquisition

movement

loss account

Shareholder 

Interest







reserve

reserve

reserve


Interest






£

£

£

£

£

£

£

£

£













Balance at











1 January 2008


767,541

1,397,500

209,332

11,038,204

4,053

1,384,558


14,801,188

129,106

14,930,294












Exchange rate movement


-

-

-

-

115,851

-

115,851

10,127

125,978

Loss for the period

 

 

-

-

-

-

-

(70,966)

(70,966)

14,171

(56,795)

Total recognised income










and expenditure


-

-

-

-

115,851

(70,966)

44,885

24,298

69,183













Share based payment










 - employee services


-

-

10,824

-

-

-

10,824

-

10,824

 

 

 










Balance at











30 June 2008

 

767,541

1,397,500

220,156

11,038,204

119,904

1,313,592

14,856,897

153,404

15,010,301













Balance at











1 July 2008


767,541

1,397,500

220,156

11,038,204

119,904

1,313,592

14,856,897

153,404

15,010,301













Exchange rate movement

-

-

-

-

323,500

-

323,500

38,690

362,190

Loss for the period


-

-

-

-

-

(1,617,061)

(1,617,061)

(16,305)

(1,633,366)

Total recognised income










and expenditure


-

-

-

-

323,500

(1,617,061)

(1,293,561)

22,385

(1,271,176)













Share based payment










 - employee services


-

-

10,825

-

-

-

10,825

-

10,825

costs of raising finance



159,625




159,625


159,625

Balance at











31 December 2008

 

767,541

1,397,500

390,606

11,038,204

443,404

(303,469)

13,733,786

175,789

13,909,575













Balance at











1 January 2009


767,541

1,397,500

390,606

11,038,204

443,404

(303,469)

13,733,786

175,789

13,909,575













Exchange rate movement

-

-

-

-

(929,537)

-

(929,537)

(31,044)

(960,581)

Loss for the period


-

-

-

-

-

(905,825)

(905,825)

25,820

(880,005)

Total recognised income










and expenditure


-

-

-

-

(929,537)

(905,825)

(1,835,362)

(5,224)

(1,840,586)













Share based payment










 - employee services


-

-

10,824

-

-

-

10,824

-

10,824

Balance at











30 June 2009

 

767,541

1,397,500

401,430

11,038,204

(486,133)

(1,209,294)

11,909,248

170,565

12,079,813



  CareCapital Group Plc

Consolidated statement of cash flows for the six months ended 30 June 2009








Six months

Six months

Year







ended

ended

ended







30 June

30 June

31 December







2009

2008

2008







Unaudited

Unaudited

Audited

 

 

 

 

 

 

£

£

£










Cash flows from operating activities






(Loss) / Profit after taxation




(880,005)

(56,795)

(1,690,161)

Adjustments








Taxation






-

76,844

(524,195)

Change in fair value of financial instruments



-

(19,916)

(92,256)

Finance costs





1,464,826

874,324

2,548,868

Finance income





(676)

(287,537)

(1,208,929)

Unrealised net revaluation gains on investment properties


(130,511)

(254,525)

1,655,932

Depreciation





13,660

21,922

38,460

Write off of development properties



69,649

-

16,933

Share based payments

 

 

 

10,824

14,432

21,649

Cash flows from operations before changes in working capital

547,767

368,749

766,301

Change in trade and other receivables



150,907

(86,183)

(13,770)

Change in trade and other payables

 

 

890,256

724,753

808,538

Cash (used) / generated from operations



1,588,930

1,007,319

1,561,069

Interest paid

 

 

 

 

(1,252,236)

(855,991)

(2,186,557)

Cash flows from operating activities

 

 

336,694

151,328

(625,488)

Cash flows from investing activities






Purchase of investment property




-

(468,574)

(520,845)

Capital expenditure on development properties



(4,825,697)

(4,719,491)

(8,461,421)

Capital expenditure on leasehold improvements



-

(400)

(400)

Purchase of plant and equipment



(13,037)

(5,629)

(31,133)

Interest received

 

 

 

 

676

2,033

10,933

Cash flows from investing activities

 

 

(4,838,058)

(5,192,061)

(9,002,866)

Cash flows from financing activities






New mortgage loans raised (Net)



2,590,777

3,994,264

22,868,788

Repayment of loans





(366,454)

(216,178)

(12,588,154)

Directors' loan (net of costs)


-

-

3,666,724

Cash flows from financing activities

 

 

2,224,323

3,778,086

13,947,358

Net decrease in cash and cash equivalents



(2,277,041)

(1,262,647)

4,319,004

Cash and cash equivalents at 1 January

 

 

2,455,257

(1,863,747)

(1,863,747)

Cash and cash equivalents at closing

 

 

178,216

(3,126,394)

2,455,257

Comprising:








 - Cash and cash equivalents




178,216

245,252

2,519,518

 - Bank overdrafts





-

(3,371,646)

(64,261)

 - Total

 

 

 

 

 

178,216

(3,126,394)

2,455,257






CareCapital Group Plc


Notes to the accounts (Unaudited)


1. Basis of preparation


The interim report of the Groups results for the six months ended 30 June 2009 was approved by the Board on 30 September 2009.


The interim financial information has not been audited and does not constitute statutory accounts as defined under section 435 of the Companies Act 2006.


The interim financial statements have been prepared in accordance with applicable accounting standards and are consistent with those accounting policies adopted in the consolidated statutory accounts of CareCapital Group Plc for the year ended 31 December 2008, prepared under IFRS as adopted in the EU. The auditors' report on those accounts, which have been filed with the Registrar of Companies, was unqualified but did contain an Emphasis of Matter with respect of the ability of the Company and the Group to continue as a going concern. The auditors' report did not contain a statement under section 498(2) or 498 (3) of the Companies Act 2006.


In the Group's annual report and accounts, the Directors stated that additional working capital would be required to fund progress on several development projects, a number of funding options had been reviewed and negotiations were progressing to secure the required finance. Since then further options have presented themselves to the Board and are also under active review. The Directors continue to have reasonable expectations of securing funding which will enable the Group to meet its debt repayment, development programme and working capital requirements for a period in excess of twelve months. 


Consequently, the financial statements have been prepared on a going concern basis. However, there can be no certainty that funding will be secured and this interim financial information does not contain any adjustments that might be necessary in the event that funding is not secured.


2. Changes in Accounting Policies


In the current financial year, the Group has adopted IAS 1, "Presentation of Financial Statements" (Revised).


"IAS 1 Presentation of Financial Statements (Revised)" includes the requirement to present a Statement of Changes in Equity as a primary statement and introduces the possibility of either a single statement of Comprehensive Income (combining the Income Statement and a Statement of Comprehensive Income) or to retain the income statement with a supplementary Statement of Comprehensive Income. The second option has been adopted by CareCapital Group Plc. As this standard is concerned with presentation only it does not have any impact on the results or net assets of the Group.


3.  Loans from CareCapital Ltd to the Group's German operations


Since the inception of CareCapital Group's investment programme in Germany, CareCapital Ltd, the Group's main operating subsidiary, has advanced loans to German Group Companies in order to facilitate the growth of the property investment and development business in that geographical area. Until 1 January 2009, such loans were treated as short term working capital loans subject to repayment. They were denominated in Euros, and exchange rate risk was carried in the UK. Any gain or loss resulting from the conversion of the loans into sterling was taken to the income statement. During January 2009, the Directors reviewed the outstanding loans and determined that it would be more appropriate to treat them as long term loans of a "quasi equity" nature. Consequently, the loans were fixed in Euros at the exchange rate applicable at 31 December 2008, and exchange rate risk passed to the German legal entities. For accounting periods after 1 January 2009 any exchange rate gains or losses arising from the translation of the German operations to sterling, will be shown in the statement of comprehensive income.  


4. Investment Property valuations


At 30 June 2009 the Group's investment properties were valued at £49,367,932 of which £26,795,854 related to the UK portfolio and £22,572,078 related to the German properties after conversion to sterling from euros at an exchange rate of 1.17357. These values reflect the underlying position at 31 December 2008 uplifted for one rent review agreed during the period. The revaluation exercise referred to in the Chairman's statement reflected a small increase on a like for like basis, which has not been booked to the accounts.


5. Earnings per Share












Six months

Six months

Year






ended

ended

ended






30 June

30 June

31 December

 

 

 

 

 

2009

2008

2008

Basic earnings per share














Basic earnings per share is calculated by dividing the profit




attributable to equity holders of the Company by the weighted




average number of ordinary shares in issue during the year,












(Loss) / profit attributable to equity holders of the Company (£)

(56,795)

(56,795)

(1,688,027)

Weighted average number of ordinary shares in issue (thousands)

76,754

76,754

76,754

(Loss) / earnings per share (pence per share)

 

(0.09)

(0.09)

(2.20)























Diluted earnings per share














The Company has two categories of dilutive potential ordinary shares - share options and warrants. A calculation is 

undertaken to determine the number of shares which could have been acquired at fair value based on the

monetary value of the subscription rights attached to outstanding share options. It is compared with the

number of shares which would have been issued assuming the exercise of the share options.















Six months

Six months

Year






ended

ended

ended






30 June

30 June

31 December

 

 

 

 

 

2009

2008

2008









(Loss) / profit attributable to equity holders of the Company (£)

(56,795)

(56,795)

(1,688,027)

Weighted average number of ordinary shares in issue (thousands)

76,754

76,754

76,754

Adjustment for share options (thousands)

 

-

-

-

Weighted average number of ordinary shares for diluted




earnings (thousands)

 

 

 

76,754

76,754

76,754

Diluted (Loss) / earnings per share (pence per share)

 

(0.09)

(0.09)

(2.20)










6. Availability of Results


These results are available on the Company's website, www.carecapital.co.uk


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR ILFFSAIIIVIA
UK 100

Latest directors dealings